You just read:

ReNetX Bio, Inc. Announces U.S. FDA Authorization to Proceed for IND Application to Treat Patients with Chronic Spinal Cord Injury

News provided by

ReNetX Bio, Inc.

Jun 19, 2019, 09:18 ET